Royce & Associates LP Takes $1.26 Million Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Royce & Associates LP bought a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 75,000 shares of the company's stock, valued at approximately $1,260,000. Royce & Associates LP owned approximately 0.12% of Guardian Pharmacy Services at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in GRDN. Seven Grand Managers LLC bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $2,515,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $5,460,000. Finally, Stephens Inc. AR purchased a new stake in shares of Guardian Pharmacy Services during the third quarter valued at about $189,000.

Insider Transactions at Guardian Pharmacy Services

In other news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the transaction, the director now owns 35,714 shares of the company's stock, valued at $499,996. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Guardian Pharmacy Services Trading Down 1.4 %

Shares of Guardian Pharmacy Services stock traded down $0.30 on Wednesday, reaching $21.26. 29,796 shares of the company were exchanged, compared to its average volume of 151,549. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. On average, equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.81 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Raymond James assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an "outperform" rating and a $21.00 price objective on the stock. Truist Financial boosted their price objective on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Finally, Stephens started coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.